Reviewed by Dr. Younghun Cho, PharmD
The score reflects that it is highly effective for its specific, short-term purpose but is reduced due to the significant risk of rebound redness with overuse.
Pharmacist's Verdict
Visine Original provides fast cosmetic relief for red eyes from minor irritation, but it should only be used occasionally as overuse can make redness worse over time.
Ingredient Analysis
Details pending pharmacist review.
Details pending pharmacist review.
Details pending pharmacist review.
Pros & Cons
Pros
- Works very quickly to reduce eye redness, often within 60 seconds.
- Effective for whitening eyes caused by minor irritants like smoke, dust, or fatigue.
- Widely available over-the-counter and is relatively inexpensive.
Cons
- Can cause significant "rebound redness," where eyes become even more red after the drop wears off, especially with frequent use.
- Masks symptoms but does not treat the underlying cause of redness, such as allergies, infection, or dry eye.
- Should not be used by individuals with narrow-angle glaucoma.
- Use is limited to no more than 72 hours without consulting a doctor.
References
- 1.FDA Drug Label — Foster and Thrive Advanced Relief Eye Drops
FDA DailyMed: Foster and Thrive Advanced Relief Eye Drops · FDA
- 2.Pediatric Visine (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity.
Daggy A, Kaplan R, Roberge R, et al., Veterinary and human toxicology, 2003 · PubMed
- 3.Part 1 - imidazolines and the changing face of nasal decongestants.
Stinson RJ, Sadofsky LR, Frontiers in pharmacology, 2025 · PubMed
- 4.More than meets the eye: a scoping review on the non-medical uses of THZ eye drops.
Menshawey E, Menshawey R, Forensic science, medicine, and pathology, 2024 · PubMed
- 5.Global Perspectives on Therapy for Noninfectious Conjunctival Hyperemia: A Narrative Review.
Toyos M, Chan CC, Alio JL, et al., Ophthalmology and therapy, 2026 · PubMed
- 6.Over-the-Counter Ocular Decongestants in the United States - Mechanisms of Action and Clinical Utility for Management of Ocular Redness.
Hosten LO, Snyder C, Clinical optometry, 2020 · PubMed